S13-187 Personalized Cancer Treatment with Topoisomerase Inhibitors Researchers in Prof. Gerald Crabtree's laboratory have developed a method for identifying cancer patients that are likely to benefit from treatment with topoisomerase IIa (TOP2A) inhibitors. Gerald Crabtree Emily Dykhuizen Diana Hargreaves Cigall Kadoch